Cobimetinib
CAS: 934660-93-2
Molecular Formula: C21H21F3IN3O2
Molecular weight:531.31
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Cobimetinib is approved for use in combination with vemurafenib (Zelboraf) for the treatment of advanced melanoma with BRAF mutation (either V600E or V600K) that cannot be removed by surgery or which has metastasized.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: